McKesson Corporation (MCK)

NYSE: MCK · IEX Real-Time Price · USD
323.88
-9.29 (-2.79%)
May 18, 2022 11:18 AM EDT - Market open
Market Cap47.08B
Revenue (ttm)263.97B
Net Income (ttm)1.11B
Shares Out145.36M
EPS (ttm)9.02
PE Ratio35.92
Forward PE13.97
Dividend$1.88 (0.58%)
Ex-Dividend DateMay 31, 2022
Volume233,509
Open331.50
Previous Close333.16
Day's Range322.73 - 333.86
52-Week Range184.43 - 339.94
Beta0.72
AnalystsBuy
Price Target358.26 (+10.6%)
Earnings DateMay 5, 2022

About MCK

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice ma...

IndustryHealth Care Providers & Services
Founded1833
CEOBrian Tyler
Employees59,000
Stock ExchangeNYSE
Ticker SymbolMCK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 21 analysts, the average rating for MCK stock is "Buy." The 12-month stock price forecast is 358.26, which is an increase of 10.62% from the latest price.

Price Target
$358.26
(10.62% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Here's Every Stock Warren Buffett Bought or Sold in the First Quarter

The Oracle of Omaha was very active in the markets.

1 day ago - The Motley Fool

7 Stock Picks to Play the Post-Pandemic Return of Dental Visits

Although Covid-19 allowed people the excuse to not see their dentist, the necessary return could benefit these dental stocks to buy. The post 7 Stock Picks to Play the Post-Pandemic Return of Dental Vis...

Other symbols:ALGNBDXCAHHSICPDCOSDC
1 week ago - InvestorPlace

5 Stocks in S&P 500 ETF Defying Losing Streak Since 2011

While most of the stocks in SPY's portfolio are deep in red, a few have outperformed so far this year, with energy stocks being the biggest gainers.

Other symbols:ADMCFLMTOXYSPY
1 week ago - Zacks Investment Research

3 Safe Stocks to Buy That Are Crushing the Market

They perhaps, not so coincidentally, are all in the pharmaceutical business.

Other symbols:BMYVRTX
1 week ago - The Motley Fool

Why McKesson Shares Are Jumping Today

McKesson Corp (NYSE: MCK) reported Q4 FY22 adjusted EPS of $5.83, +15% Y/Y, and missing the consensus of $6.04. Revenues increased 12% Y/Y to $66.10 billion, surpassing the consensus of $63.61 billion.

1 week ago - Benzinga

McKesson (MCK) Q4 Earnings Miss, Revenues Beat Estimates

McKesson's (MCK) fiscal fourth-quarter 2022 results benefit from segmental growth.

1 week ago - Zacks Investment Research

Stocks That Lift This JPMorgan Fund In Down Market

Most mutual funds have losses this year amid the market's sell-off. But JPMorgan Large Cap Value Fund is in positive territory.

1 week ago - Investors Business Daily

McKesson (MCK) Lags Q4 Earnings Estimates

McKesson (MCK) delivered earnings and revenue surprises of -3.80% and 3.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

McKesson Reports Fiscal 2022 Fourth-Quarter Results

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2022 fourth-quarter financial results. Results can be accessed on McKesson's Investor Relations website at invest...

1 week ago - Business Wire

Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD

The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.

Other symbols:CAHPODD
1 week ago - Zacks Investment Research

Distributors Agree to Opioid Settlement With Washington State

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement...

Other symbols:ABCCAH
2 weeks ago - Business Wire

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

McKesson Declares Quarterly Dividend

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 47 cents per share of common stock. The dividend will be payable on Jul...

2 weeks ago - Business Wire

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

4 weeks ago - Zacks Investment Research

10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!

The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.

1 month ago - Benzinga

Bet on These 4 Low-Beta, High-Dividend MedTech Stocks for 2022

Stocks like Becton, Dickinson and Company (BDX), Phibro Animal Health (PAHC), McKesson Corporation (MCK) and UnitedHealth Group Inc (UNH) are right picks with strong fundamentals.

Other symbols:BDXPAHCUNH
1 month ago - Zacks Investment Research

5 Dividend Growth Stocks for Safe Income Amid Volatility

The Kroger (KR), NVIDIA (NVDA), Jones Lang LaSalle (JLL), Paychex (PAYX) and McKesson (MCK) could be compelling picks amid market volatility.

Other symbols:JLLKRNVDAPAYX
1 month ago - Zacks Investment Research

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 month ago - Zacks Investment Research

McKesson's Board of Directors Elects W. Roy Dunbar as New Director

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committ...

1 month ago - Business Wire

3 Lucrative Stocks From the Promising Dental Supplies Industry

Despite the COVID-19 pandemic-induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain f...

Other symbols:CAHWST
1 month ago - Zacks Investment Research

McKesson (MCK) Soars to 52-Week High, Time to Cash Out?

McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

1 month ago - Zacks Investment Research

Should Value Investors Consider McKesson (MCK) Stock Now?

Let's see if McKesson (MCK) stock is a good choice for value-oriented investors right now from multiple angles.

1 month ago - Zacks Investment Research

McKesson (MCK) Is Up 6.34% in One Week: What You Should Know

Does McKesson (MCK) have what it takes to be a top stock pick for momentum investors? Let's find out.

1 month ago - Zacks Investment Research

Here's Why You Should Buy McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

2 months ago - Zacks Investment Research

U.S. should review drugmakers' opioid settlement tax breaks - House panel

The U.S. Justice and Treasury Departments should review the tax deductions four drugmakers made related to their $26 billion opioid settlement, the U.S. House Oversight and Reform Committee said in a st...

Other symbols:ABCCAHJNJ
2 months ago - Reuters